This study, "Pro re nata versus fixed aflibercept regimen for neovascular age-related macular degeneration: a systematic review and meta-analysis," used rigorous methods to analyze the outcomes of existing clinical trials. The analysis showed that a fixed, bimonthly injection schedule of aflibercept was superior to an "as needed" (pro re nata) approach, leading to better visual acuity improvements after 12 months, with the standardized mean difference of 0.56 (95% CI 0.36–0.75, I² = 0%, p < 0.00001). The choice of aflibercept is significant as it was a relatively new anti-VEGF therapy at the time, and establishing optimal dosing schedules has important implications for patient outcomes.
Today, Yan Martha Putri is a , applying her specialized knowledge in aging and general medicine to help patients. Her transition from a tireless student to a dedicated medical professional serves as a powerful reminder to aspiring doctors that the path to success is paved with hard work and a refusal to settle for anything less than excellence.
is a prominent Indonesian medical professional and researcher recognized for her academic excellence and contributions to ophthalmology and geriatric health. Her career is marked by high-level education in both Indonesia and the United Kingdom, alongside published research in international medical journals. Academic Background and Honors yan martha putri
Medical students are the future front-line educators for the Indonesian public. If those within the medical community are not fully aware of the vaccination protocols or have not undergone screening themselves, it becomes significantly harder to build public trust in national programs.
Beyond her clinical and research work, Yan Martha Putri has been featured in student-focused media for her academic perseverance. Her journey from SMAN 1 Batam to the top of Indonesia's medical education system has been cited as an inspiration for aspiring medical students. She also provides health information through digital platforms like Hello Sehat . This study, "Pro re nata versus fixed aflibercept
She graduated Cum Laude from the University of Indonesia (2014–2020), where she was also highly active in student leadership, including the Student Union of International Class (STUNICA).
She has co-authored several systematic reviews and clinical studies, notably: Today, Yan Martha Putri is a , applying
: Co-authored critical systematic reviews analyzing treatment intervals for neovascular age-related macular degeneration (nAMD). Her work evaluates real-world visual outcomes of fixed dosing versus proactive "Treat-and-Extend" regimens utilizing Anti-VEGF agents like Aflibercept and Ranibizumab.
In 2025, an actor’s reach is defined by their digital footprint. has mastered this landscape exceptionally well. With millions of followers across Instagram, TikTok, and Twitter, she engages with her fanbase—known as "Yanatics" —regularly.